JACC. Case reports · 2025
Radial Approach Renal Denervation: A First-in-Man Case With the 4-F TIVUS Catheter.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tuvali Ortal, Blatt Alex, Elbaz-Greener Gabby, Ben-Dov Iddo Z, Spaulding Christian, Zidar James P, Kirtane Ajay J, Jonas Michael
Аннотация
BACKGROUND: Renal denervation (RDN) is an effective procedure for the treatment of uncontrolled hypertension, typically performed via the femoral approach. Although RDN is generally safe, vascular complications remain the most frequent adverse events.
CASE SUMMARY: A 57-year-old man with resistant hypertension was enrolled in the Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study (REDUCED 1) clinical study. He underwent bilateral RDN using a novel 4-F ultrasound-based catheter via left radial arterial access. The procedure was uneventful, and at 3-month follow-up, ambulatory and office blood pressure showed marked reductions.
DISCUSSION: This first-in-human case supports the feasibility and safety of transradial RDN using a dedicated 4-F ultrasound catheter. The radial approach may reduce access-site complications and enable same-day discharge. Future studies are needed to confirm the benefits of this system.
TAKE-HOME MESSAGE: Transradial RDN using a novel 4-F ultrasound catheter is safe, feasible, and may offer procedural and patient-care advantages over femoral access.
CASE SUMMARY: A 57-year-old man with resistant hypertension was enrolled in the Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study (REDUCED 1) clinical study. He underwent bilateral RDN using a novel 4-F ultrasound-based catheter via left radial arterial access. The procedure was uneventful, and at 3-month follow-up, ambulatory and office blood pressure showed marked reductions.
DISCUSSION: This first-in-human case supports the feasibility and safety of transradial RDN using a dedicated 4-F ultrasound catheter. The radial approach may reduce access-site complications and enable same-day discharge. Future studies are needed to confirm the benefits of this system.
TAKE-HOME MESSAGE: Transradial RDN using a novel 4-F ultrasound catheter is safe, feasible, and may offer procedural and patient-care advantages over femoral access.